Vibrio Cholerae neuraminidase susceptible n-acetyl neuraminic acid (sialic acid) levels in human leukaemia
- 10 Downloads
Cell surface vibrio Cholerae neuraminidase (VCN) susceptible sialic acid has been studied in leucocytes of normal human subjects and patients with acute myeloid, acute lymphatic and chronic lymphatic leukaemia as well as in myeloid metaplasia. The mean VCN susceptible sialic acid released in normal lymphocytes was 222±72 n mole/109 cells as compared to 158±n mole/109 cells in leukaemic lymphocytes, and 178±48 n mole/109 cells in leukaemic granulocytes. This release of surface sialic acid by VCN may play a part in increasing immunogenicity of leukaemic cells for immunotherapy.
KeywordsSialic Acid Acute Myelogenous Leukaemia Normal Lymphocyte Leukaemic Cell Phate Buffer Saline
Unable to display preview. Download preview PDF.
- Gottschalk, A. and Bhargava, A. S. 1971. The Enzymes, Vol. V, 3rd Ed. New York, Academic Press, p. 321.Google Scholar
- Harris, R., Ukaeljiofo, E., Pierce, G. E. and Yang, J. P. 1969. Cellular and humoral immunity to different types of human neoplasms. Nature (Lond.) 220, 1352.Google Scholar
- Lichtmann, M. A. and Weed, R. I. 1970. Electrophoretic mobility and N-acetylneuraminic acid content of normal and leukaemic lymphocytes and granulocytes. Blood, 35, 12.Google Scholar
- Lindenmann, J. and Klein, P. A. 1967. Immunological aspects of viral oncolysis: recent results. Cancer Res. 9, 1.Google Scholar
- Lundgren, G. and Simmons, R. L. 1971. Effect of neuraminidase on the stimulatory capacity of cells in mixed lymphocyte cultures. Clin Exptl. Immunol. 9, 915.Google Scholar
- Mehrishi, J. N. 1974. Cell surface membrane interactions with special reference to lymphocytes in leukaemia. Behring inst. Mitt No. 55, 290.Google Scholar
- Seiler, F. R. and Sedlack, H. H. 1974. Alterations of immunological phenomena by neuraminidase. Behring, Inst. Mitt., No. 55, 254Google Scholar
- Sethi, K. K. and Brandis, H. 1973. Synergistic cytoxic effect of macrophages and normal mouse serum on neuraminidase-treated leukaemia cells. Europ. J. Cancer 9, 809Google Scholar
- Simmons, R. L., Rios, A. 1974. Immunospecific regression of methycholanthrene fibrosarcoma with the use of neuraminidase. Israel Med. Sci. 10, 925.Google Scholar